Vav: Function and regulation in hematopoietic cell signaling

Stem Cells

Volumn 14, Issue 3, 1996, Pages 250-268

  Bonnefoy Bérard, Nathalie ^a   Munshi, Anil ^b   Yron, Ilana ^b   Wu, Shaokee ^b   Collins, Tassie L ^b   Deckert, Marcel ^b   Shalom Barak, Tali ^b   Giampa, Leslie ^b   Herbert, Elizabeth ^b   Hernandez, Jerry ^b   Meller, Nahum ^b   Couture, Clement ^b   Altman, Amnon ^b  

^a EDOUARD HERRIOT HOSPITAL   (France)

^b LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY   (United States)

Author keywords

Antigen receptor; Dbl homology; Guanine nucleotide exchange; Hematopoietic cell; Protein tyrosine kinase; Ras; Signal transduction; Vav

Indexed keywords

ONCOPROTEIN;

GENE EXPRESSION; GENETIC TRANSFECTION; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; HUMAN; NONHUMAN; ONCOGENE; PROTEIN ANALYSIS; PROTEIN DOMAIN; REVIEW; SIGNAL TRANSDUCTION;

EID: 0342596009     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1002/stem.140250     Document Type: Review

References (125)

1. Cantley LC, Auger KR, Carpenter C et al. Oncogenes and signal transduction. Cell 1991;64:281-302.
2. Schlessinger J, Ullrich A. Growth factor signaling by receptor tyrosine kinases. Neuron 1992;9:383-391.
3. Koch CA, Anderson D, Moran MF et al. SH2 and SH3 domains: elements that control interactions of cytoplasmic signaling molecules. Science 1991;252:668-674.
4. Mayer BJ, Baltimore D. Signaling through SH2 and SH3 domains. Trends Cell Biol 1993;3:8-13.
5. Pawson T, Schlessinger J. SH2 and SH3 domains. Curr Biol 1993;3:434-442.
6. Johnson GL, Vaillancourt RR. Sequential protein kinase reactions controlling cell growth and differentiation. Curr Opin Cell Biol 1994;6:230-238.
7. Altman A, Mustelin T, Coggeshall KM. T lymphocyte activation: a biological model of signal transduction. CRC Critical Rev Immunol 1990;10:347-391.
8. Mustelin T. T cell antigen receptor signaling: three families of tyrosine kinases and a phosphatase. Immunity 1994;1:351-356.
9. Weiss A, Littman DR. Signal transduction by lymphocyte antigen receptors. Cell 1994;76:263-274.
10. Pleiman CM, D'Ambrosio D, Cambier JC. The B-cell antigen receptor complex: structure and signal transduction. Immunol Today 1994;15:393-399.
11. Kishimoto T, Taga T, Akira S. Cytokine signal transduction. Cell 1994;76:253-262.
12. Thomas ML. The regulation of B- and T-lymphocyte activation by the transmembrane protein tyrosine phosphatase CD45. Curr Opin Cell Biol 1994;6:247-252.
13. Chan AC, Iwashima M, Turck CW et al. ZAP-70: a 70 kd protein-tyrosine kinase that associates with the TCR ζ chain. Cell 1992;71:649-662.
14. Kolanus W, Romero C, Seed B. T cell activation by clustered tyrosine kinases. Cell 1993;74:171-183.
15. Taniguchi T, Kobayashi T, Kondo J et al. Molecular cloning of a porcine gene syk that encodes a 72-kDa protein-tyrosine kinase showing high susceptibility to proteolysis. J Biol Chem 1991;266:15790-15796.
16. Katzav S, Martin-Zanca D, Barbacid M. vav, a novel human oncogene derived from a locus ubiquitously expressed in hematopoietic cells. EMBO J 1989;8:2283-2290.
17. Hu P, Margolis B, Schlessinger J. Vav: a potential link between tyrosine kinases and Ras-like GTPases in hematopoietic cell signaling. Bioessays 1993;15:179-183.
18. Puil L, Pawson T. Vagaries of Vav. Curr Biol 1992;2:275-277.
19. Katzav S, Cleveland JL, Heslop HE et al. Loss of the amino-terminal helix-loop-helix domain of the vav proto-oncogene activates its transforming potential. Mol Cell Biol 1991;11:1912-1920.
20. Adams JM, Houston H, Allen J et al. The hematopoietically expressed vav proto-oncogene shares homology with the dbl GDP-GTP exchange factor, the her gene and a yeast gene (CDC24) involved in cytoskeletal organization. Oncogene 1992;7:611-618.
21. Coppola S, Bryant S, Koda T et al. Mechanism of activation of the vav protooncogene. Cell Growth Differ 1991;2:95-105.
22. Martinerie C, Cannizzaro LA, Croce CM et al. The human VAV proto-oncogene maps to chromosome region 19p12→19pl3.2. Hum Genet 1990;86:65-68.
23. Bustelo XR, Rubin SD, Suen KL et al. Developmental expression of the vav protooncogene. Cell Growth Differ 1993;4:297-308.
24. Bustelo XR, Ledbetter JA, Barbacid M. Product of vav proto-oncogene defines a new class of tyrosine protein kinase substrates. Nature 1992;356:68-71.
25. Margolis B, Hu P, Katzav S et al. Tyrosine phosphorylation of vav proto-oncogene product containing SH2 domain and transcription factor motifs. Nature 1992;356:71-74.
26. av/heterogenous ribonucleoprotein K interaction. J Biol Chem 1994;269:20225-20228.
27. Clevenger CV, Ngo W, Sokol DL et al. Vav is necessary for prolactin-stimulated proliferation and is translocated into the nucleus of a T-cell line. J Biol Chem 1995;270:13246-13253.
28. Katzav S. vav: a molecule for all haemopoiesis? Br J Haematol 1992;81:141-144.
29. Steele RE. A transcription factor (?) joins the SH2 crowd. Trends Biochem Sci 1992;17:205-206.
30. Boguski MS, Bairoch A, Attwood TK et al. Protovav and gene expression. Nature 1992;358:113.
31. Bustelo XR, Suen KL, Michael WM et al. Association of the vav proto-oncogene product with poly(rC)-specific RNA-binding proteins. Mol Cell Biol 1995;15:1324-1332.
32. Kazanietz MG, Bustelo XR, Barbacid M et al. Zinc finger domains and phorbol ester pharmacophore. Analysis of binding to mutated form of protein kinase C ζ and the vav and c-raf proto-oncogene products. J Biol Chem 1994;269:11590-11594.
33. Ono Y, Fujii T, Igarashi K et al. Phorbol ester binding to protein kinase C requires a cysteinerich zinc-finger-like sequence. Proc Natl Acad Sci USA 1989;86:4868-4871.
34. Hubbard SR, Bishop WR, Kirschmeier P et al. Identification and characterization of zinc binding sites in protein kinase C. Science 1991;254:1776-1779.
35. Ahmed S, Lee J, Kozma R et al. A novel functional target for tumor-promoting phorbol esters and lysophosphatidic acid. The p21 rac-GTPase activating protein n-chimaerin. J Biol Chem 1993;268:10709-10712.
36. Maruyama IN, Brenner S. A phorbol ester/diacylglycerol-binding protein encoded by the unc-13 gene of Caenorhabditis elegans. Proc Natl Acad Sci USA 1991;88:5729-5733.
37. Pasteris NG, Cadle A, Logie LJ et al. Isolation and characterization of the fasciogenital dysplasia (Aarskog-Scott syndrome) gene: a putative Rho/Rac guanine nucleotide exchange factor. Cell 1994;79:669-678.
38. Whitehead I, Kirk H, Tognon C et al. Expression cloning of lfc, a novel oncogene with structural similarities to guanine nucleotide exchange factors and to the regulatory region of protein kinase C. J Biol Chem 1995;270:18388-18395.
39. Gulbins E, Coggeshall KM, Baier G et al. Direct stimulation of Vav guanine nucleotide exchange activity for Ras by phorbol esters and diglycerides. Mol Cell Biol 1994;14:4749-4758.
40. Hannun YA. The sphingomyelin cycle and the second messenger function of ceramide. J Biol Chem 1994;269:3125-3128.
41. Lozano J, Berra E, Municio MM et al. Protein kinase C ζ isoform is critical for κB- dependent promoter activation by sphingomyelinase. J Biol Chem 1994;269:19200-19202.
42. Katzav S. Single point mutations in the SH2 domain impair the transforming potential of vav and fail to activate proto-vov. Oncogene 1993;8:1757-1763.
43. Katzav S, Sutherland M, Packham G et al. The protein tyrosine kinase ZAP-70 can associate with the SH2 domain of proto-Vav. J Biol Chem 1994;269:32579-32585.
44. Ihle JN, Kerr IM. Jaks and Stats in signaling by the cytokine receptor superfamily. Trends Genet 1995;11:69-74.
45. BCR/ABL EMBO J 1995;14:257-265.
46. Bustelo XR, Barbacid M. Tyrosine phosphorylation of the vav proto-oncogene product in activated B cells. Science 1992;256:1196-1199.
47. Songyang Z, Shoelson SE, McGlade J et al. Specific motifs recognized by the SH2 domains of Csk, 3BP2, fps/fes, GRB-2, HCP, SHC, Syk, and Vav. Mol Cell Biol 1994;14:2777-2785.
48. Songyang Z, Shoelson SE, Chaudhuri M et al. SH2 domains recognize specific phosphopeptide sequences. Cell 1993;72:767-778.
49. Tuveson DA, Carter RH, Soltoff SP et al. CD 19: a surrogate kinase insert domain that binds phosphatidylinositol 3-kinase in B lymphocytes. Science 1993;260:986-988.
50. Weng WK, Jarvis L, LeBien TW. Signaling through CD 19 activates Vav/mitogen-activated protein kinase pathway and induces formation of a CD19/Vav/phosphatidylinositol 3-kinase complex in human B cells. J Biol Chem 1994;269:32514-32521.
51. Hanazono Y, Sasaki K, Odai H et al. Tyrosine phosphorylation of the proto-oncogene product Vav and its association with the adapter Grb2/Ash in a human leukemia cell line UT-7. Jpn J Cancer Res 1995;86:336-341.
52. Ye Z-S, Baltimore D. Binding of Vav to Grb2 through dimerization of Src homology 3 domains. Proc Natl Acad Sci USA 1994;91:12629-12633.
53. Ramos-Morales F, Druker BJ, Fischer S. Vav binds to several SH2/SH3 containing proteins in activated lymphocytes. Oncogene 1994;9:1917-1923.
54. Quilliam LA, Khosravi-Far R, Huff SY et al. Guanine nucleotide exchange factors: activators of the Ras superfamily of proteins. Bioessays 1995;17:395-404.
55. Boguski MS, McCormick F. Proteins regulating Ras and its relatives. Nature 1993;399:643-654.
56. Feig LA. Guanine-nucleotide exchange factors: a family of positive regulators of Ras and related GTPases. Curr Opin Cell Biol 1994;6:204-211.
57. Galland F, Katzav S, Birnbaum D. The products of the mcf-2 and vav proto-oncogenes and of the yeast gene cdc-24 share sequence similarities. Oncogene 1992;7:585-587.
58. Chang EC, Barr M, Wang Y et al. Cooperative interaction of S. pombe proteins required for mating and morphogenesis. Cell 1994;79:131.
59. Miki T, Smith CL, Long JE et al. Oncogene ect2 is related to regulators of small GTP-binding proteins. Nature 1993;362:462-465.
60. Chan AM, McGovern ES, Catalano G et al. Expression cDNA cloning of a novel oncogene with sequence similarity to regulators of small GTP-binding proteins. Oncogene 1994;9:1057-1063.
61. Toksoz D, Williams DA. Novel human oncogene lbc detected by transfection with distinct homology regions to signal transduction products. Oncogene 1994;9:621-628.
62. Heisterkamp N, Kaartinen V, van Soest S et al. Human ABR encodes a protein with GAPrac activity and homology to the DBL nucleotide exchange factor domain. J Biol Chem 1993;268:16903-16906.
63. Habets GGM, Scholtes EHM, Zuydgeest D et al. Identification of an invasion-inducing gene, Tiam-1, that encodes a protein with homology to GDP-GTP exchangers for Rho-like proteins. Cell 1994;77:537-549.
64. Horii Y, Beeler JF, Sakaguchi K et al. A novel oncogene, ost, encodes a guanine nucleotide exchange factor that potentially links Rho and Rac signaling pathways. EMBO J 1994;13:4776-4786.
65. Whitehead I, Kirk H, Kay R. Retroviral transduction and oncogenic selection of a cDNA encoding Dbs, a homolog of the Dbl guanine nucleotide exchange factor. Oncogene 1995;10:713-721.
66. Zheng Y, Cerione RA, Bender A. Control of the yeast bud-site assembly GTPase Cdc42. Catalysis of guanine nucleotide exchange by Cdc24 and stimulation of GTPase activity by Bem3. J Biol Chem 1994;269:2369-2372.
67. Hart MJ, Eva A, Evans T et al. Catalysis of guanine nucleotide exchange on the CDC42Hs protein by the dbl oncogene product. Nature 1991;354:311-314.
68. Hart MJ, Eva A, Zangrilli D et al. Cellular transformation and guanine nucleotide exchange activity are catalyzed by a common domain on the dbl oncogene product. J Biol Chem 1994;269:62-65.
69. Yaku H, Sasaki T, Takai Y. The Dbl oncogene product as a GDP/GTP exchange protein for the Rho family: its properties in comparison with those of Smg GDS. Biochem Biophys Res Commun 1994;198:811-817.
70. Zheng Y, Olson MF, Hall A et al. Direct involvement of the small GTP-binding protein Rho in lbc oncogene function. J Biol Chem 1995;270:9031-9034.
71. Michiels F, Habets GGM, Stam JC et al. A role for Rac in Tiam1-induced membrane ruffling and invasion. Nature 1995;375:338-340.
72. Chuang TH, Xu X, Kaartinen V et al. Abr and Bcr are multifunctional regulators of the Rho GTP-binding protein family. Proc Natl Acad Sci USA 1995;92:10282-10286.
73. Shou C, Farnsworth CL, Neel BG et al. Molecular cloning of cDNAs encoding a guanine-nucleotide-releasing factor for Ras p21. Nature 1992;358:351-354.
74. Cen H, Papageorge AG, Zippel R et al. Isolation of multiple mouse cDNAs with coding homology to Saccharomyces cerevisiae CDC25: identification of a region related to Bcr, Vav, Dbl and CDC24. EMBO J 1992;11:4007-4015.
75. Cen H, Papageorge AG, Vass WC et al. Regulated and constitutive activity by CDC25Mm (GRF), a Ras-specific exchange factor. Mol Cell Biol 1993;13:7718-7724.
76. Musacchio A, Gibson T, Rice P et al. The PH domain: a common piece in the structural patchwork of signalling proteins. Trends Biochem Sci 1993;18:343-348.
77. Touhara K, Inglese J, Pitcher JA et al. Binding of G protein βγ-subunits to pleckstrin homology domains. J Biol Chem 1994;269:10217-10220.
78. Yao L, Kawakami Y, Kawakami T. The pleckstrin homology domain of Bruton tyrosine kinase interacts with protein kinase C. Proc Natl Acad Sci USA 1994;91:9175-9179.
79. Harlan JE, Hajduk PJ, Yoon HS et al. Pleckstrin homology domains bind to phosphatidylinositol-4,5-biphosphate. Nature 1994;371:168-170.
80. Ferguson KM, Lemmon MA, Schlessinger J et al. Crystal structure at 2.2 Å resolution of the pleckstrin homology domain from human dynamin. Cell 1994;79:199-209.
81. Gulbins E, Coggeshall KM, Baier G et al. Tyrosine kinase-stimulated guanine nucleotide exchange activity of Vav in T cell activation. Science 1993;260:822-825.
82. Gulbins E, Langlet C, Baier G et al. Tyrosine phosphorylation and activation of Vav GTP/GDP exchange activity in antigen receptor-triggered B cells. J Immunol 1994;152:2123-2129.
83. Kiener PA, Rankin BM, Burkhardt AL et al. Cross-linking of Fc gamma receptor (Fc gamma RI) and receptor II (Fc gamma RII) on monocytic cells activates a signal transduction pathway common to both FC receptors that involves the stimulation of p72 Syk protein tyrosine kinase. J Biol Chem 1993;268:24442-24448.
84. Darby C, Geahlen RL, Schreiber AD. Stimulation of macrophage Fc Gamma RIIIA activates the receptor-associated protein tyrosine kinase Syk and induces phosphorylation of multiple proteins including p95Vav and p62/GAP-associated protein. J Immunol 1994;152:5429-5437.
85. Geng Y, Gulbins E, Altman A et al. Monocyte deactivation by interleukin 10 via inhibition of tyrosine kinase activity and the Ras signaling pathway. Proc Natl Acad Sci USA 1994;91:8602-8606.
86. ras. J Exp Med 1994;180:1067- 1076.
87. August A, Gibson S, Kawakami Y et al. CD28 is associated with and induces the immediate tyrosine phosphorylation and activation of the Tec family kinase ITK/EMT in the human Jurkat leukemic T-cell line. Proc Natl Acad Sci USA 1994;91:9347-9351.
88. Evans GA, Howard OM, Erwin R et al. Interleukin-2 induces tyrosine phosphorylation of the vav proto-oncogene product in human T cells: lack of requirement for the tryosine kinase Ick. Biochem J 1993;294:339-342.
89. Sato S, Katagiri T, Takaki S et al. IL-5 receptor-mediated tyrosine phosphorylation of SH2/SH3-containing proteins and activation of Bruton's tyrosine and Janus 2 kinases. J Exp Med 1994;180:2101-2111.
90. Platanias LC, Sweet ME. Interferon α induces rapid tyrosine phosphorylation of the vav protooncogene product in hematopoietic cells. J Biol Chem 1994;269:3143-3146.
91. Miura O, Miura Y, Nakamura N et al. Induction of tyrosine phosphorylation of Vav and expression of Pim-1 correlates with Jak2-mediated growth signaling from the erythropoietin receptor. Blood 1994;84:4135-4141.
92. Yuo A, Kitagawa S, Iki S et al. Tyrosine phosphorylation of vav protooncogene product in primary human myelogenous leukemia cells stimulated by granulocyte colony-stimulating factor. Biochem Biophys Res Commun 1995;211:677-685.
93. vav, in human hematopoietic cells. J Biol Chem 1992;267:18021-18025.
94. Dosil M, Wang S, Lemischka IR. Mitogenic signalling and substrate specificity of the Flk2/Flt3 receptor tyrosine kinase in fibroblasts and interleukin 3-dependent hematopoietic cells. Mol Cell Biol 1993;13:6572-6585.
95. Rottapel R, Turck CW, Casteran N et al. Substrate specificity and identification of a putative binding site for PI3K in the carboxy tail of the murine Flt3 receptor tyrosine kinase. Oncogene 1994;9:1755-1765.
96. Uddin S, Katzav S, White MF et al. Insulin-dependent tyrosine phosphorylation of the vav protooncogene product in cells of hematopoietic origin. J Biol Chem 1995;270:7712-7716.
97. Gupta S, Weiss A, Kumar G et al. The T-cell antigen receptor utilizes Lck, Raf-1, and MEK-1 for activating mitogen-activated protein kinase. Evidence for the existence of a second protein kinase C-dependent pathway in an Lck-negative Jurkat cell mutant. J Biol Chem 1994;269:17349-17357.
98. Straus DB, Weiss A. Genetic evidence for the involvement of the Ick tyrosine kinase in signal transduction through the T cell antigen receptor. Cell 1992;70:585-593.
99. syk protein tyrosine kinase: efficient phosphorylation of motifs recognized by Src homology 2 domains of the Src family. FEBS Lett 1995;367:149-152.
100. Wulf GM, Adra CN, Lim B. Inhibition of hematopoietic development from embryonic stem cells by antisense vav RNA. EMBO J 1993;12:5065-5074.
101. Keller G, Kennedy M, Papayannopoulou T et al. Hematopoietic commitment during embryonic stem cell differentiation in culture. Mol Cell Biol 1993;13:473-486.
102. Zmuidzinas A, Fischer KD, Lira SA et al. The vav proto-oncogene is required early in embryogenesis but not for hematopoietic development in vitro. EMBO J 1995;14:1-11.
103. -/- mouse embryonic stem cells. Proc Natl Acad Sci USA 1994;91:12755-12759.
104. Chen J, Gorman JR, Stewart V et al. Generation of normal lymphocyte populations by Rb-deficient embryonic stem cells. Curr Biol 1993;3:405-413.
105. + thymocytes. Nature 1995;374:474-477.
106. Tarakhovsky A, Turner M, Schaal S et al. Defective antigen receptor-mediated proliferation of B and T cells in the absence of Vav. Nature 1995;374:467-470.
107. vav activity. Mol Cell Biol 1995;15:4337-4346.
108. Holsinger LJ, Spencer DM, Austin DJ et al. Signal transduction in T lymphocytes using a conditional allele of Sos. Proc Natl Acad Sci USA 1995;92:9810-9814.
109. Ron D, Graziani G, Aaronson SA et al. The N-terminal region of proto-dbl down regulates its transforming activity. Oncogene 1989;4:1067-1072.
110. Ron D, Zannini M, Lewis M et al. A region of proto-dbl essential for its transforming activity shows sequence similarity to a yeast cell cycle gene, CDC24, and the human breakpoint cluster gene, bcr. New Biol 1991;3:372-379.
111. Bustelo XR, Suen KL, Leftheris K et al. Vav cooperates with Ras to transform rodent fibroblasts but is not a Ras GDP/GTP exchange factor. Oncogene 1994;9:2405-2413.
112. Khosravi-Far R, Chrzanowska-Wodnicka M, Solski PA et al. Dbl and Vav mediate transformation via mitogen-activated protein kinase pathways that are distinct from those activated by oncogenic Ras. Mol Cell Biol 1994;14:6848-6857.
113. Gulbins E, Coggeshall KM, Langlet C et al. Specific activation of Ras in vitro and in intact fibroblasts by the Vav guanine nucleotide exchange protein. Mol Cell Biol 1994;14:906-913.
114. Minden A, Lin A, Claret F-X et al. Selective activation of the JNK signaling cascade and c-Jun transcriptional activity by the small GTPases Rac and Cdc42Hs. Cell 1995;81:1147-1157.
115. Vojtek AB, Cooper JA. Rho family members: activators of MAP kinase cascades. Cell 1995;82:527-529.
116. Chant J, Stowers L. GTPase cascades choreographing cellular behavior: movement, morphogenesis and more. Cell 1995;81:1-4.
117. Altman A, Gulbins E. Vav. In: Huber LA, Zerial M, Tooze J, eds. Guidebook to the Small GTPases. Oxford: Oxford University Press, 1996 (in press).
118. Satoh T, Nakafuku M, Kaziro Y. Function of Ras as a molecular switch in signal transduction. J Biol Chem 1992;267:24149-24152.
119. Cantrell D. G proteins in lymphocyte signaling. Curr Opin Immunol 1994;6:380-384.
120. ras upon T-cell activation. Nature 1990;346:719-723.
121. ras. J Immunol 1993;151:4513-4522.
122. ras derived by alternate splicing of the human n-chimerin gene, is selectively expressed in brain regions and testes. Mol Cell Biol 1993;13:4986-4998.
123. Mosteller RD, Man JW, Broek D. Identification of residues of the H-Ras protein critical for functional interaction with guanine nucleotide exchange factors. Mol Cell Biol 1994;14:1104-1112.
124. Katzav S, Packham G, Sutherland M et al. Vav and Ras induce fibroblast transformation by overlapping signaling pathways which require c-Myc function. Oncogene 1995;11:1079-1088.
125. Henske EP, Short MP, Jozwiak S et al. Identification of VAV2 on 9q34 and its exclusion as the tuberous sclerosis gene TSC1. Ann Hum Genet 1995;59:25-37.